Technical / Understanding the requirements on sustainability reporting

05 July 2016 Steve Brown

Login to access this content

Up to 2015/16, there have been two rule books for trust and foundation trust accounts – the Department’s Manual for accounts and what was Monitor’s Annual reporting manual. While both allow for environmental reporting, neither could be said to have been particularly bossy about it.

In a section on performance analysis (paragraph 2.15), the Manual for accounts says that organisations should provide information on its key performance measures. There are no direct requirements for sustainable development reporting, though the Department says requirements for such reporting would be advised of in frequently asked questions. There was no mention of sustainability in any of the FAQs issued by the Department in 2015/16.

The Annual reporting manual goes a little further, but not much. ‘The annual report may, at the NHS foundation trust’s discretion, include additional reporting covering sustainability, equality, and the NHS Constitution,’ it says in paragraph 7.7.

In 2016/17, there will be a single group accounting manual covering the accounts of all NHS bodies. And on the face of it, a tougher stance does seem to be emerging. The consultation draft says helpfully: ‘Reporting entities are expected to comply with mandatory sustainability reporting requirements. It is envisaged that such reporting will be integral throughout the annual report and accounts and not a separate standalone report.’

This begs an obvious question: what are the mandatory reporting requirements? The place to look is the Treasury’s Financial reporting manual (FReM).  Both the 2015/16 and the 2016/17 FReMs (paragraphs 5.2.10 and 5.2.11) repeat the ‘comply with mandatory requirements’ call and underline that reporting should be integral and not separate from the annual report.

It adds that ‘entities falling within the scope of reporting under the Greening government commitments’ should also report performance against sustainability targets.

An annex flags up environmental and sustainability guidance, but even the most recent version of this guidance states explicitly that NHS bodies are not covered by the requirements. It adds that the NHS has its own carbon reduction strategy and also assesses performance using the ‘Good Corporate Citizenship tool developed with the Sustainable Development Commission’.

The lack of clarity – or at least detail – appears to have influenced actual practice. Analysis undertaken by the SDU shows that only one third of annual reports for CCGs and NHS providers included a good sustainability report in 2014/15.

However, there are specific requirements for NHS bodies to report on sustainability. CCG annual reporting guidance for 2013/14 – and still live on the NHS England site – confirms this for CCGs, while, for NHS providers, the requirement comes from the terms and conditions written into the NHS standard contract. A provider must ‘demonstrate progress on climate change adaptation, mitigation and sustainable development’ and, importantly, ‘provide a summary of that progress in its annual report’.

Providers looking for further details are pointed in the direction of Sustainable Development Unit guidance on sustainable development management plans. This does suggest that marginal abatement cost curves could be used in annual reports to explain environmental performance. But that is the only mention of annual reports. For those putting reporting into practice, the SDU produces detailed reporting guidance and provides checklists and reporting templates.

The 2016/17 group accounting manual is currently out for consultation. Healthcare Finance understands that the SDU has been in discussions with the Department about strengthening the clause in paragraph 2.15, and there is an expectation that this will happen.

There is a good argument that sustainability can help organisations meet existing financial challenges. But improving the clarity around reporting requirements would be a good first step.

In brief 

NHS RightCare has published four more commissioning for value packs to help clinical commissioning groups identify opportunities for improving value. The packs cover cancer and tumours, mental health and dementia, maternity and early years, and musculoskeletal, trauma and injuries.

NHS Improvement has published details of regional workshops that will look at the 2017/18 tariff. Four events will take place in July and one in August in Birmingham, London and Leeds.

NHS Employers has published the detailed technical requirements for commissioners and practices that hold a general medical services contract (GMS) under agreed GMS contract changes for 2016/17. It also issued the requirements for practices offering enhanced services and vaccination programmes.

NHS Improvement draft guidance for providers on local stakeholder engagement is a helpful reminder of the importance of good governance, especially in the current financial and operational environment, the HFMA said. In its response to the draft, it added that all local organisations must take a similar approach.



NICE update: Go ahead for GreenLight prostate treatment

NICE has recommended GreenLight XPS to treat benign prostatic hyperplasia (BPH) in non-high-risk patients (medical technology guidance MTG29), writes Nicola Bodey. It provides another treatment option for benign BPH alongside monopolar and bipolar transurethral resection of the prostate (TURP). NICE estimates 13,600 people with BPH are eligible to have GreenLight XPS, with uptake anticipated to be 50% from year two onwards and around 6,800 people having the procedure each year, either as an elective inpatient or day-case procedure.

This guidance is a cost saving for the NHS. The level of savings depends on how many procedures are done as day cases and the cost of the GreenLight XPS fibres.

NICE anticipates more people will have day-case procedures with GreenLight XPS than with TURP. This will reduce the number of bed days needed by people with BPH, allowing providers to better utilise beds.

The reduction in bed days is a non-cash-releasing saving, with additional day cases generating increased income for providers due to the day case uplift for these procedures.

An annual commitment to purchase fibres above a minimum number secures provision of a GreenLight XPS console at no extra cost. The average cost per fibre is £550.

The approach is also expected to reduce the number of adverse events associated with treatment. Savings range from £1.3m when 36% of procedures with GreenLight XPS are done as day cases, to £3.2 million when this reaches 70%. Based on 53% of GreenLight XPS procedures being done as day cases, the guidance is estimated to save the NHS around £2.3m per year (or £4,200 per 100,000 people). This technology is commissioned by clinical commissioning groups. Providers are NHS hospital trusts.

Nicola Bodey, NICE senior business analyst